Seven Fleet Capital Management »

Traws Pharma shares owned by Seven Fleet Capital Management

Quarter-by-quarter ownership of Traws Pharma (TRAW) shares owned by Seven Fleet Capital Management from 13F filings

Historical chart of Seven Fleet Capital Management investment in Traws Pharma

Tip: Access up to 7 years of quarterly data

All positions including Traws Pharma held by Seven Fleet Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Traws Pharma by Seven Fleet Capital Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $56k 49k 1.13

More positions owned by Seven Fleet Capital Management

Cg Oncology (CGON)
Soleno Therapeutics (SLNO)
Revolution Medicines (RVMD)
Liquidia Corporation Com New (LQDA)
Compass Therapeutics (CMPX)
Exelixis (EXEL)
Axsome Therapeutics (AXSM)
Tyra Biosciences (TYRA)
Cogent Biosciences (COGT)
Tango Therapeutics (TNGX)
Xencor (XNCR)
Pharvaris N V (PHVS)
Terns Pharmaceuticals (TERN)
Belite Bio Sponsored Ads (BLTE)
Dyne Therapeutics (DYN)

View all positions for Seven Fleet Capital Management

Top funds holding Traws Pharma

Ikarian Capital
OrbiMed Advisors
Adage Capital Partners GP
Boothbay Fund Management
ADAR1 Capital Management
Vanguard Group
Geode Capital Management
Seven Fleet Capital Management
XTX Topco
State Street Corporation
Two Sigma Investments
Susquehanna International
BlackRock
UBS Group
SBI Securities

View all funds holding Traws Pharma